Exhibit 107

Calculation of Filing Fee Table

S-3

(Form Type)

Vivos Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule			Amount Registered(1)			Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Fees to Be Paid	Equity	Common Stock		457	(c)		6,440,532	(2)	$	2.35	(3)	$	15,135,250.20		0.00014760	$	2,233.96
	Total Offering Amounts											$	15,135,250.20
	Total Fees Previously Paid												—		—		—
	Total Fee Offsets												—		—		—
	Net Fee Due															$	2,233.96

(1)	Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the common stock, par value $0.0001 per share (“Common Stock”) of Vivos Therapeutics, Inc., in connection with any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.
(2)	Represents shares of Common Stock offered by the selling stockholder issuable upon the exercise of the Pre-Funded Warrant and the Common Stock Purchase Warrant.
(3)	With respect to the shares of Common Stock offered by the selling stockholder, estimated at $2.35 per share, the average of the high and low prices as reported on The Nasdaq Capital Market on July 24, 2024, for the purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act.